Luis Tristan-Lopez
Overview
Explore the profile of Luis Tristan-Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Wilson E, Estrada-Soto S, Rubio-Osornio M, Tristan-Lopez L, Navarrete-Vazquez G, Gutierrez-Hernandez A, et al.
J Pharm Pharmacol
. 2024 Oct;
77(3):396-403.
PMID: 39374988
Background: Agastache mexicana is used in traditional medicine to treat anxiety, insomnia, pain, among others. In a previous study, the methanolic extract exerted anxiolytic and sedative effects, as observed behaviorally,...
2.
Martinez-Gopar P, Perez-Rodriguez M, Angeles-Lopez Q, Tristan-Lopez L, Gonzalez-Espinosa C, Perez-Severiano F
Mol Neurobiol
. 2023 Jan;
60(5):2678-2690.
PMID: 36701109
Toll-like receptors (TLRs) are central players in innate immunity responses. They are expressed in glial cells and neurons, and their overactivation leads to the production of proinflammatory molecules, neuroinflammation, and...
3.
Garcia-Pastor C, Navarro-Garcia de Llano J, Balcazar-Padron J, Tristan-Lopez L, Rios C, Diaz-Ruiz A, et al.
Neurosurg Focus
. 2022 Mar;
52(3):E12.
PMID: 35231887
Objective: In this study, the authors sought to define the differences in the incidence of delayed cerebral ischemia (DCI) between patients treated with dapsone and those treated with placebo. Secondary...
4.
Martinez-Gopar P, Perez-Rodriguez M, Rodriguez-Manzo G, Garduno-Gutierrez R, Tristan-Lopez L, Angeles-Lopez Q, et al.
J Neurochem
. 2021 Oct;
160(2):256-270.
PMID: 34665461
Huntington´s disease (HD) is a pathological condition that can be studied in mice by the administration of quinolinic acid (QUIN), an agonist of the N-methyl-d-aspartate receptor (NMDAR) that induces NMDAR-mediated...
5.
Garcia-Martinez B, Montes S, Tristan-Lopez L, Quintanar-Guerrero D, Melgoza L, Baron-Flores V, et al.
Biometals
. 2021 Apr;
34(3):687-700.
PMID: 33900531
Neurodegenerative disorders have been linked to the decrease of copper concentrations in different regions of the brain. Therefore, intake of micronutrient supplements could be a therapeutic alternative. Since the copper...
6.
Ortega-Vazquez A, Mayen-Lobo Y, Davila-Ortiz de Montellano D, Tristan-Lopez L, Avina-Cervantes C, Rios C, et al.
Drug Dev Res
. 2020 Dec;
82(5):685-694.
PMID: 33336447
Clozapine (CLZ) is an atypical antipsychotic and the gold standard for refractory psychosis treatment. However, there is little information regarding pharmacogenetics of CLZ in patients with refractory psychosis and its...
7.
Rivera-Mancia S, Tristan-Lopez L, Hernandez-Diaz K, Rivera-Espinosa L, Rios C, Montes S
J Trace Elem Med Biol
. 2020 Jul;
62:126625.
PMID: 32717575
Introduction: As a consequence of the loss of liver function in chronic liver disease, increased levels of ammonia, manganese, and glutamine have been observed in the brain of hepatic encephalopathy...
8.
Vaquero-Baez M, Diaz-Ruiz A, Tristan-Lopez L, Avina-Cervantes C, Torner C, Ramirez-Bermudez J, et al.
BMC Psychiatry
. 2019 Oct;
19(1):295.
PMID: 31597566
Purpose: The aim of present study is to measure plasma clozapine (CLZ) and N-desmethyl clozapine (DMC) as biomarkers to correlate drug concentrations with the appearance of preclinical adverse hematic effects....
9.
Morales-Martinez A, Sanchez-Mendoza A, Martinez-Lazcano J, Pineda-Farias J, Montes S, El-Hafidi M, et al.
Nutr Neurosci
. 2016 Mar;
20(7):388-395.
PMID: 26928375
Essential fatty acids have an important effect on oxidative stress-related diseases. The Huntington's disease (HD) is a hereditary neurologic disorder in which oxidative stress caused by free radicals is an...
10.
Aguirre-Vidal Y, Montes S, Tristan-Lopez L, Anaya-Ramos L, Teiber J, Rios C, et al.
Neurotoxicology
. 2015 Apr;
48:166-70.
PMID: 25842176
Parkinson's disease (PD) is a neurodegenerative disorder characterized by loss of the pigmented dopaminergic neurons in the substantia nigra pars compacta with subsequent striatal dopamine (DA) deficiency and increased lipid...